提供支持According to VCBeat, Wenyifuxin, a health management service platform, got a new round strategic financing, and it is invested by Legendstar Capital.
Founded in December 2016, Wenyifuxin focuses on overseas health travel. It received the angel round of financing from Dalian Yifang Group and Xu Liaoran. In December 2018, it raised another exclusive strategic investment from Wuxing Holdings.
At this stage, Wenyifuxin has invested many third-party institutions in the United States, Japan and other countries. This investment includes assisted reproduction, overseas health travel, anti-aging beauty and high-end medical examination. In addition, Wenyifuxin has also reached strategic cooperation with high-end resources in Europe, Russia, and Southeast Asian countries.
In terms of services, Wenyifuxin has launched rich and customized one-stop service to meet the needs of different customers. Now Wenyifuxin has cooperated with National Pregnancy Center and launched the recruitment of city partners across China.
"Assisted reproductive technology is popular, and hot money continues to flood in. We will combine domestically assisted reproductive products and our medical resources to continuously introduce new products, providing customers with a full range of product service experience," said a stuff of Wenyifuxin.
"This investment is promising. Its founders know what rich people need in term of health management. And the core team has a strong ability to build a comprehensive business circle. Wenyifuxin can meet the needs of Chinese high-net-worth customers. Surely it has great potential," said Leng Yan, partner of Legendstar Capital.
渝公网安备 50011202502165号
